eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | mucopolysaccharidosis is |
| Comorbidity | C0011847|diabetes |
| Sentences | 8 |
| PubMedID- 25806426 | We explored the level of pmps in young patients with type 1 diabetes in relation to inflammation, glycemic control, micro-vascular complications and carotid intima media thickness (cimt). |
| PubMedID- 21838881 | The relationship between plasma opg concentrations and signs of myocardial ischemia on mps in patients with type 2 diabetes has previously been investigated by avignon et al. |
| PubMedID- 21470000 | Background: this article reports a prolonged trial with insulin pumps implanted in patients with type 1 diabetes showing poor glucose control and a high rate of complications. |
| PubMedID- 24396429 | A previous study using euglycemic-hyperinsulinemic glucose clamps in patients with type ii diabetes demonstrated that in the skeletal muscle of the diabetes group, the ho-1 mrna expression levels were 55% lower than those in the control group prior to clamp placement; however, the levels increased by 70-fold following clamp placement. |
| PubMedID- 25370368 | Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in australia. |
| PubMedID- 20634911 | We studied the cellular adhesion molecule (cam) profile of circulating emps in patients with and without diabetes mellitus type 2, who were undergoing elective cardiac catheterization. |
| PubMedID- 20705776 | To address this question, dr. rita basu (28) performed hyperglycemic, hyperinsulinemic clamps in people with so-called severe diabetes, whose fasting glucose concentrations averaged ∼12 mmol/l; in people with mild diabetes, whose fasting glucose concentrations averaged ∼8 mmol/l; and in people who did not have diabetes, whose fasting glucose concentrations averaged ∼5 mmol/l (fig. |
| PubMedID- 22737657 | Hyperglycemic-euglycemic clamps in three patients with lipoatrophic diabetes have shown remarkable improvement in insulin sensitivity after leptin treatment [26]. |
Page: 1